Background:
There are limited data for prognostic and diagnostic use of natriuretic peptides in intensive care unit (ICU) patients. We evaluate amino-terminal brain natriuretic peptide (NT-proBNP) in the medical ICU, specifically its correlation with noncardiac admission diagnosis and prognosis of critically ill patients.
Methods:
NT-proBNP (pg/mL) was measured in 179 ICU patients without acute decompensated heart failure or acute coronary syndrome. Death during hospitalization (mortality), APACHE II score, laboratory data, echocardiograms, medical history, and demographics were assessed. NT-proBNP concentrations were compared with established cutoffs for congestive heart failure (>450 pg/mL for patients <50 years of age, >900 pg/mL for patients 50-70 years of age, and >1800 pg/mL for patients >70 years of age). Predictors of mortality and of NT-proBNP were analyzed by regression analysis. Tertiles were compared by analysis of variance and chi-squared test.
Results:
NT-proBNP was elevated in these ICU patients (median 2139 pg/mL, 25th percentile 540 pg/mL, 75% percentile 7389 pg/mL). Severity of illness and renal dysfunction (APACHE II score and serum creatinine) increased with rising NT-proBNP. The incidence of acute respiratory distress syndrome, sepsis, death, history of coronary artery disease (CAD) or congestive heart failure (all P <.05) increased with each tertile. Independent predictors of increased NT-proBNP were creatinine (P <.001), CAD (P <.001), APACHE II score (P <.05), and sepsis (P < or =.001). Overall hospital mortality was 26%, and log NT-proBNP (P <.05), APACHE II (P < or =.001), and CAD (P <.05) were independent predictors of mortality.
Conclusions:
For patients admitted to the ICU without decompensated heart failure or acute coronary syndrome, NT-proBNP concentrations are markedly elevated, especially in patients with sepsis. NT-proBNP strongly and independently predicts mortality. However, NT-proBNP should not be used to direct volume management in critically ill patients.
Citing Articles
Prognostic value of combining cardiac myosin-binding protein C and N-terminal pro-B-type natriuretic peptide in patients without acute coronary syndrome treated at medical cardiac intensive care units.
Nishimura H, Ishii J, Takahashi H, Ishihara Y, Nakamura K, Kitagawa F
Heart Vessels. 2024; .
PMID: 39630269
DOI: 10.1007/s00380-024-02492-5.
Inflammation and Circulating Natriuretic Peptide Levels.
Fish-Trotter H, Ferguson J, Patel N, Arora P, Allen N, Bachmann K
Circ Heart Fail. 2020; 13(7):e006570.
PMID: 32507024
PMC: 7375923.
DOI: 10.1161/CIRCHEARTFAILURE.119.006570.
Prognostic Value of N-terminal Probrain Natriuretic Peptide for Patients with Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis.
Ni Q, Li C, Lin H
Biomed Res Int. 2020; 2020:3472615.
PMID: 32337240
PMC: 7165325.
DOI: 10.1155/2020/3472615.
Can NT-pro BNP Levels Predict Prognosis of Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the Intensive Care Unit?.
Ediboglu O, Kirakli C
Balkan Med J. 2018; 35(6):422-426.
PMID: 29966999
PMC: 6251376.
DOI: 10.4274/balkanmedj.2018.0006.
Pro-BNP versus MEDS Score in Determining the Prognosis of Sepsis Patients; a Diagnostic Accuracy Study.
Shojaee M, Safari S, Sabzghabaei A, Alavi-Moghaddam M, Arhami Dolatabadi A, Kariman H
Emerg (Tehran). 2018; 6(1):e4.
PMID: 29503829
PMC: 5827050.
Comparison of prognostic value of N-terminal pro-brain natriuretic peptide in septic and non-septic intensive care patients.
Ozcan N, Ozcan A, Kaymak C, Basar H, Kotanoglu M, Kose B
Arch Med Sci. 2017; 13(2):418-425.
PMID: 28261297
PMC: 5332440.
DOI: 10.5114/aoms.2015.54196.
Retrospective study on prognostic importance of serum procalcitonin and amino-terminal pro-brain natriuretic peptide levels as compared to Acute Physiology and Chronic Health Evaluation IV Score on Intensive Care Unit admission, in a mixed Intensive....
Mehta C, Dara B, Mehta Y, Tariq A, Joby G, Singh M
Ann Card Anaesth. 2016; 19(2):256-62.
PMID: 27052066
PMC: 4900355.
DOI: 10.4103/0971-9784.179616.
Elevated high-sensitive troponin T on admission is an indicator of poor long-term outcome in patients with subarachnoid haemorrhage: a prospective observational study.
Oras J, Grivans C, Bartley A, Rydenhag B, Ricksten S, Seeman-Lodding H
Crit Care. 2016; 20:11.
PMID: 26781032
PMC: 4717610.
DOI: 10.1186/s13054-015-1181-5.
High-Sensitive Troponin T and N-Terminal Pro B-Type Natriuretic Peptide for Early Detection of Stress-Induced Cardiomyopathy in Patients with Subarachnoid Hemorrhage.
Oras J, Grivans C, Dalla K, Omerovic E, Rydenhag B, Ricksten S
Neurocrit Care. 2015; 23(2):233-42.
PMID: 25634642
DOI: 10.1007/s12028-015-0108-y.
B-type natriuretic peptide as a predictor of outcome in a general intensive care unit.
Grassi P, Calderan C, Vassallo M, Cageggi D, Stenner E, Biasioli B
HSR Proc Intensive Care Cardiovasc Anesth. 2013; 3(1):59-66.
PMID: 23439789
PMC: 3484602.
B-type natriuretic peptide predicts long-term prognosis in a cohort of critically ill patients.
Baptista R, Jorge E, Sousa E, Pimentel J
Heart Int. 2012; 6(2):e18.
PMID: 22355485
PMC: 3282435.
DOI: 10.4081/hi.2011.e18.
The effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysis.
Siegelaar S, Hickmann M, Hoekstra J, Holleman F, DeVries J
Crit Care. 2011; 15(5):R205.
PMID: 21914173
PMC: 3334749.
DOI: 10.1186/cc10440.
Utile or futile: biomarkers in the ICU.
Balmelli C, Drexler B, Mueller C
Crit Care. 2011; 15(2):131.
PMID: 21457515
PMC: 3219324.
DOI: 10.1186/cc10056.
Usefulness of N-terminal pro-brain natriuretic peptide and C-reactive protein to predict ICU mortality in unselected medical ICU patients: a prospective, observational study.
Wang F, Pan W, Pan S, Wang S, Ge Q, Ge J
Crit Care. 2011; 15(1):R42.
PMID: 21272380
PMC: 3221971.
DOI: 10.1186/cc10004.
